000520 — Samil Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Samil Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	1,341	-5,347	-28.3	1,664	-5,629
Depreciation
Amortisation
Non-Cash Items	9,782	9,678	8,806	7,734	12,975
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-7,547	-7,626	-9,613	-2,599	-11,598
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	7,775	1,417	4,154	11,746	2,590
Capital Expenditures	-17,211	-33,091	-48,656	-24,391	-5,612
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	12,622	-12,217	12,720	4,613	-749
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-4,589	-45,308	-35,936	-19,778	-6,361
Financing Cash Flow Items	-1,969	-1,893	-1,877	-7,603	-7,494
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-3,323	31,874	29,706	8,483	7,982
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-721	-12,005	-2,089	-997	4,231